Yarrow Bioscience, Inc.
YARW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566044
No open-market purchases or sales by Yarrow Bioscience, Inc. insiders were filed in the last 90 days; 46 institutions reported holding it in 13F filings for Q2 2026, worth $8.79M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Yarrow Bioscience, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- +12 vs. Q3 2023
- Shares held
- 7.90M
- +7.52M (+1,959.6%) vs. Q3 2023
- Total value
- $18.4M
- +$16.9M (+1,094.7%) vs. Q3 2023
- New holders
- 13
- 9 more added
- Sold out
- 1
- 4 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting YARW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $8.79M |
| Q1 2026 | 46 | $8.49M |
| Q4 2025 | 45 | $5.35M |
| Q3 2025 | 36 | $1.33M |
| Q2 2025 | 46 | $13.4M |
| Q1 2025 | 38 | $11.5M |
| Q4 2024 | 35 | $23.4M |
| Q3 2024 | 33 | $14.3M |
| Q2 2024 | 32 | $16.1M |
| Q1 2024 | 32 | $22.9M |
| Q4 2023 | 33 | $18.4M |
| Q3 2023 | 21 | $1.54M |
| Q2 2023 | 20 | $1.63M |
| Q1 2023 | 23 | $1.10M |
| Q4 2022 | 41 | $1.10M |
| Q3 2022 | 41 | $1.84M |
| Q2 2022 | 41 | $3.25M |
| Q1 2022 | 45 | $5.63M |
| Q4 2021 | 55 | $12.5M |
| Q3 2021 | 65 | $20.1M |
| Q2 2021 | 73 | $64.0M |
| Q1 2021 | 87 | $152.4M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Yarrow Bioscience, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Indiana Trust & Investment Management CO | 12 | $28 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 22 | $51 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 146 | $341 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 172 | $400 | 0.00% | +67+63.8% | Added |
| Russell Investments Group, Ltd. | 187 | $435 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 790 | $1.84K | 0.00% | +521+193.7% | Added |
| UBS Group AG | 846 | $1.97K | 0.00% | +662+359.8% | Added |
| MB, Levis & Associates, LLC | 1,041 | $2.43K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,265 | $3.00K | 0.00% | −930−42.4% | Reduced |
| Morgan Stanley | 1,868 | $4.35K | 0.00% | −311−14.3% | Reduced |
| Bank of America Corp | 2,785 | $6.49K | 0.00% | −638−18.6% | Reduced |
| US Bancorp | 4,444 | $10.4K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 10,043 | $23.0K | 0.00% | +10,043 | New |
| State Street Corp | 11,665 | $27.2K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 17,273 | $40.2K | 0.00% | +17,273 | New |
| Staley Capital Advisers Inc | 36,472 | $85.0K | 0.00% | +13,000+55.4% | Added |
| Northern Trust Corp | 36,951 | $86.1K | 0.00% | +36,951 | New |
| Renaissance Technologies LLC | 46,376 | $108.0K | 0.00% | +20,400+78.5% | Added |
| BlackRock Inc. | 47,297 | $110.2K | 0.00% | +2,358+5.2% | Added |
| Vanguard Group Inc | 49,582 | $115.5K | 0.00% | +4,687+10.4% | Added |
| Fred Alger Management, LLC | 60,055 | $139.9K | 0.00% | +60,055 | New |
| Susquehanna International Group, LLP | 60,323 | $140.6K | 0.00% | −15,448−20.4% | Reduced |
| Geode Capital Management, LLC | 94,343 | $219.8K | 0.00% | +66,809+242.6% | Added |
| Prelude Capital Management, LLC | 118,100 | $275.2K | 0.02% | +118,100 | New |
| Exome Asset Management LLC | 118,100 | $275.2K | 0.27% | +118,100 | New |
| Palo Alto Investors LP | 445,434 | $1.04M | 0.09% | +445,434 | New |
| AlphaCentric Advisors LLC | 668,151 | $1.56M | 1.04% | +668,151 | New |
| DSC Advisors, L.P. | 696,465 | $1.62M | 2.75% | +581,465+505.6% | Added |
| Parkman Healthcare Partners LLC | 696,470 | $1.62M | 0.23% | +696,470 | New |
| Soleus Capital Management, L.P. | 703,868 | $1.64M | 0.18% | +703,868 | New |
| Citadel Advisors LLC | 1,181,088 | $2.75M | 0.00% | +1,181,088 | New |
| Eventide Asset Management, LLC | 1,394,336 | $3.25M | 0.05% | +1,394,336 | New |
| Cormorant Asset Management, LP | 1,394,336 | $3.25M | 0.16% | +1,394,336 | New |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −127−100.0% | Sold out |